Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypercytokinemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04359784
What this trial is testing

Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center 27
Not applicableStudy completedNCT04913298
What this trial is testing

Prospective Study for the Application of Cytosorb® in Critically Ill Patients

Who this might be right for
RhabdomyolysisAcute Liver InjuryCytokine Storm
Ludwig-Maximilians - University of Munich 57
Not applicableUnknownNCT05414162
What this trial is testing

Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

Who this might be right for
DLBCLMultiple MyelomaCytokine Release Syndrome+6 more
University Hospital, Bonn 60
Testing effectiveness (Phase 2)Study completedNCT05019287
What this trial is testing

Menstrual Blood Stem Cells in Severe Covid-19

Who this might be right for
Covid19Cytokine Storm
Avicenna Research Institute 29
Large-scale testing (Phase 3)Study completedNCT04443881
What this trial is testing

Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)

Who this might be right for
COVID-19 Pnemonia
Fundacion Miguel Servet 179
Testing effectiveness (Phase 2)Study completedNCT06390748
What this trial is testing

Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes

Who this might be right for
SepsisLymphocyte Disorder TImmunologic Paralysis+4 more
Lin Chen 150
Not applicableStudy completedNCT05408325
What this trial is testing

Intercellular Adhesion Molecule-1 and TNF-α in Patients With COVID-19

Who this might be right for
COVID-19Cytokine Storm
Benha University 100
Not applicableStudy completedNCT06279910
What this trial is testing

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

Who this might be right for
SARS-CoV 2 Pneumonia
Complejo Hospitalario Universitario de Albacete 230
Testing effectiveness (Phase 2)Looking for participantsNCT07657312
What this trial is testing

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

Who this might be right for
Cytokine Release SyndromeRecurrent Multiple MyelomaRefractory Multiple Myeloma
Naresh Bumma 35
Not applicableUnknownNCT05576220
What this trial is testing

Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy

Who this might be right for
Febrile Neutropenia
IDION Inc. 210
Post-approval studies (Phase 4)Looking for participantsNCT07609940
What this trial is testing

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 30
Large-scale testing (Phase 3)Ended earlyNCT04370236
What this trial is testing

INB03 for the Treatment of Pulmonary Complications From COVID-19

Who this might be right for
COVID-19
Inmune Bio, Inc. 79
Testing effectiveness (Phase 2)Looking for participantsNCT07106671
What this trial is testing

A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma

Who this might be right for
CRS - Cytokine Release SyndromeMyeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT04358406
What this trial is testing

Rhu-pGSN for Severe Covid-19 Pneumonia

Who this might be right for
Sars-CoV2
BioAegis Therapeutics Inc. 64
Post-approval studies (Phase 4)Study completedNCT04730323
What this trial is testing

TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience

Who this might be right for
Covid19
FMH College of Medicine and Dentistry 93
Testing effectiveness (Phase 2)Study completedNCT05349669
What this trial is testing

Jafron Haemoadsorption During Cardiopulmonary Bypass

Who this might be right for
Cytokine Release Syndrome
Anthea Hospital Bari 40
Not applicableUnknownNCT04306705
What this trial is testing

Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19

Who this might be right for
Covid-19SARSCytokine Storm+2 more
Tongji Hospital 120
Not applicableStudy completedNCT06415656
What this trial is testing

VitalTraq for the Detection of CRS

Who this might be right for
Hematologic Malignancy
Duke University 32
Testing effectiveness (Phase 2)Looking for participantsNCT05905328
What this trial is testing

Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy

Who this might be right for
Cytokine Release Syndrome
CytoAgents, Inc. 54
Not applicableUnknownNCT04904783
What this trial is testing

Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study

Who this might be right for
COVID-19Pneumonia
Mahatma Gandhi Institute of Medical Sciences 20
Next Page